257 related articles for article (PubMed ID: 20007702)
1. Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology.
Marchenko S; Chernyavsky AI; Arredondo J; Gindi V; Grando SA
J Biol Chem; 2010 Feb; 285(6):3695-3704. PubMed ID: 20007702
[TBL] [Abstract][Full Text] [Related]
2. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens.
Chernyavsky AI; Arredondo J; Kitajima Y; Sato-Nagai M; Grando SA
J Biol Chem; 2007 May; 282(18):13804-12. PubMed ID: 17344213
[TBL] [Abstract][Full Text] [Related]
3. Critical Role of the Neonatal Fc Receptor (FcRn) in the Pathogenic Action of Antimitochondrial Autoantibodies Synergizing with Anti-desmoglein Autoantibodies in Pemphigus Vulgaris.
Chen Y; Chernyavsky A; Webber RJ; Grando SA; Wang PH
J Biol Chem; 2015 Sep; 290(39):23826-37. PubMed ID: 26260795
[TBL] [Abstract][Full Text] [Related]
4. Role of Dsg1- and Dsg3-Mediated Signaling in Pemphigus Autoantibody-Induced Loss of Keratinocyte Cohesion.
Walter E; Vielmuth F; Wanuske MT; Seifert M; Pollmann R; Eming R; Waschke J
Front Immunol; 2019; 10():1128. PubMed ID: 31178865
[TBL] [Abstract][Full Text] [Related]
5. p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris.
Mao X; Sano Y; Park JM; Payne AS
J Biol Chem; 2011 Jan; 286(2):1283-91. PubMed ID: 21078676
[TBL] [Abstract][Full Text] [Related]
6. Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation.
Saito M; Stahley SN; Caughman CY; Mao X; Tucker DK; Payne AS; Amagai M; Kowalczyk AP
PLoS One; 2012; 7(12):e50696. PubMed ID: 23226536
[TBL] [Abstract][Full Text] [Related]
7. Pemphigus vulgaris antibodies target the mitochondrial nicotinic acetylcholine receptors that protect keratinocytes from apoptolysis.
Chernyavsky A; Chen Y; Wang PH; Grando SA
Int Immunopharmacol; 2015 Nov; 29(1):76-80. PubMed ID: 25998908
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of ST18 in pemphigus vulgaris drives a self-amplifying p53-dependent pathomechanism resulting in decreased desmoglein 3 expression.
Assaf S; Vodo D; Malovitski K; Mohamad J; Bergson S; Feller Y; Malki L; Sarig O; Sprecher E
Sci Rep; 2022 Apr; 12(1):5958. PubMed ID: 35396567
[TBL] [Abstract][Full Text] [Related]
9. MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris.
Mao X; Li H; Sano Y; Gaestel M; Mo Park J; Payne AS
J Invest Dermatol; 2014 Jan; 134(1):68-76. PubMed ID: 23657501
[TBL] [Abstract][Full Text] [Related]
10. Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris.
Chernyavsky A; Amber KT; Agnoletti AF; Wang C; Grando SA
J Biol Chem; 2019 Mar; 294(12):4520-4528. PubMed ID: 30692201
[TBL] [Abstract][Full Text] [Related]
11. Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris.
Luyet C; Schulze K; Sayar BS; Howald D; Müller EJ; Galichet A
PLoS One; 2015; 10(3):e0119809. PubMed ID: 25748204
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of mitochondrial damage in keratinocytes by pemphigus vulgaris antibodies.
Kalantari-Dehaghi M; Chen Y; Deng W; Chernyavsky A; Marchenko S; Wang PH; Grando SA
J Biol Chem; 2013 Jun; 288(23):16916-16925. PubMed ID: 23599429
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
[TBL] [Abstract][Full Text] [Related]
15. Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus.
Walter E; Vielmuth F; Rotkopf L; Sárdy M; Horváth ON; Goebeler M; Schmidt E; Eming R; Hertl M; Spindler V; Waschke J
Sci Rep; 2017 Jun; 7(1):3579. PubMed ID: 28620161
[TBL] [Abstract][Full Text] [Related]
16. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
[TBL] [Abstract][Full Text] [Related]
17. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes.
Cirillo N; Femiano F; Gombos F; Lanza A
FEBS Lett; 2006 May; 580(13):3276-81. PubMed ID: 16698018
[TBL] [Abstract][Full Text] [Related]
18. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.
Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S
Front Immunol; 2018; 9():1935. PubMed ID: 30233569
[TBL] [Abstract][Full Text] [Related]
19. Role of Src and Cortactin in Pemphigus Skin Blistering.
Kugelmann D; Rötzer V; Walter E; Egu DT; Fuchs MT; Vielmuth F; Vargas-Robles H; Schnoor M; Hertl M; Eming R; Rottner K; Schmidt A; Spindler V; Waschke J
Front Immunol; 2019; 10():626. PubMed ID: 31024527
[TBL] [Abstract][Full Text] [Related]
20. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
Cirillo N; Femiano F; Gombos F; Lanza A
Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
